open access

Vol 89, No 6 (2018)
Research paper
Published online: 2018-06-29
Get Citation

Role of lymphadenectomy in disease-free and overall survival on low risk endometrium cancer patients

Can Turkler12, Mehmet Kulhan12, Nur Gozde Kulhan12, Nahit Ata12, Muzaffer Sanci2, Mehmet Ozeren2
DOI: 10.5603/GP.a2018.0053
·
Pubmed: 30010179
·
Ginekol Pol 2018;89(6):311-315.
Affiliations
  1. Department of Obstetrics and Gynecology, Erzincan University, Turkey
  2. Izmir Provincial Health Directorate, Izmir, Turkey

open access

Vol 89, No 6 (2018)
ORIGINAL PAPERS Gynecology
Published online: 2018-06-29

Abstract

Objectives: Evaluation of the effect of lymphadenectomy in disease-free and overall survival on the low risk corpus cancer.

Material and methods: Between 1994 and 2012, a total of 257 patients with endometrioid type, grade 1 or 2, myometrial invasion < 1/2, no intraoperative evidence of macroscopic extrauterine spread was treated surgically. Pelvic lymphadenec­tomy was performed in 184 cases, and not performed in 73 cases.

Results: There was no difference between two groups about tumor sizes. Also lymphovascular space invasion and histo­logic grade of two groups were similar. Omission of LA did not worsen DFS and OS in early stage low risk corpus cancer.

Conclusions: Patients who have low risk corpus cancer, can be treated optimally with hysterectomy only.

Abstract

Objectives: Evaluation of the effect of lymphadenectomy in disease-free and overall survival on the low risk corpus cancer.

Material and methods: Between 1994 and 2012, a total of 257 patients with endometrioid type, grade 1 or 2, myometrial invasion < 1/2, no intraoperative evidence of macroscopic extrauterine spread was treated surgically. Pelvic lymphadenec­tomy was performed in 184 cases, and not performed in 73 cases.

Results: There was no difference between two groups about tumor sizes. Also lymphovascular space invasion and histo­logic grade of two groups were similar. Omission of LA did not worsen DFS and OS in early stage low risk corpus cancer.

Conclusions: Patients who have low risk corpus cancer, can be treated optimally with hysterectomy only.

Get Citation

Keywords

endometrial cancer, low risk, lymphadenectomy

About this article
Title

Role of lymphadenectomy in disease-free and overall survival on low risk endometrium cancer patients

Journal

Ginekologia Polska

Issue

Vol 89, No 6 (2018)

Article type

Research paper

Pages

311-315

Published online

2018-06-29

DOI

10.5603/GP.a2018.0053

Pubmed

30010179

Bibliographic record

Ginekol Pol 2018;89(6):311-315.

Keywords

endometrial cancer
low risk
lymphadenectomy

Authors

Can Turkler
Mehmet Kulhan
Nur Gozde Kulhan
Nahit Ata
Muzaffer Sanci
Mehmet Ozeren

References (23)
  1. Kulhan M, Kulhan G, Nayki U, et al. Assessment of clinicopathological features, evaluation of treatment, and prognosis of clear cell and serous papillary endometrial carcinoma. Ginekol Pol. 2016; 87(8): 570–574.
  2. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1): 7–30.
  3. Arem H, Irwin ML, Zhou Y, et al. Physical activity and endometrial cancer in a population-based case-control study. Cancer Causes Control. 2011; 22(2): 219–226.
  4. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol. 1989; 96(8): 889–892.
  5. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009; 105(2): 103–104.
  6. Fotopoulou C, Savvatis K, Kraetschell R, et al. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status. Eur J Obstet Gynecol Reprod Biol. 2010; 149(2): 199–203.
  7. Hidaka T, Nakashima A, Shima T, et al. Systemic lymphadenectomy cannot be recommended for low-risk corpus cancer. Obstet Gynecol Int. 2010; 2010: 490219.
  8. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23(16): 3668–3675.
  9. Zhang H, Jia L, Zhang Q, et al. Therapeutic role of systematic retroperitoneal lymphadenectomy in endometrial cancer. Bull Cancer. 2012; 99(2): E10–E17.
  10. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008; 100(23): 1707–1716.
  11. Kitchener H, Swart AMC, Qian Q, et al. ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009; 373(9658): 125–136.
  12. FIGO stages 1988 revision. Gynecol Oncol. 1989; 35: 125–126.
  13. Mariani A, Webb MJ, Keeney GL, et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000; 182(6): 1506–1519.
  14. Convery PA, Cantrell LA, Di Santo N, et al. Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma. Gynecol Oncol. 2011; 123(1): 65–70.
  15. Milam MR, Java J, Walker JL, et al. Gynecologic Oncology Group. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol. 2012; 119(2 Pt 1): 286–292.
  16. Shah C, Johnson EB, Everett E, et al. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol. 2005; 99(3): 564–570.
  17. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol. 1998; 71(3): 340–343.
  18. Schink JC, Rademaker AW, Miller DS, et al. Tumor size in endometrial cancer. Cancer. 1991; 67(11): 2791–2794, doi: 10.1002/1097-0142(19910601)67:11<2791::aid-cncr2820671113>3.0.co;2-s.
  19. Kamura T, Yahata H, Shigematsu T, et al. Predicting pelvic lymph node metastasis in endometrial carcinoma. Gynecol Oncol. 1999; 72(3): 387–391.
  20. Mariani A, Dowdy SC, Keeney GL, et al. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecol Oncol. 2004; 95(1): 120–126.
  21. Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008; 109(1): 11–18.
  22. Kang S, Todo Y, Watari H. Risk assessment of lymph node metastasis before surgery in endometrial cancer: do we need a clinical trial for low-risk patients? J Obstet Gynaecol Res. 2014; 40(2): 322–326.
  23. Kang S, Kang WD, Chung HH, et al. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study. J Clin Oncol. 2012; 30(12): 1329–1334.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl